CBD shows promise against lung cancer in lab studies through multiple anti-tumor mechanisms
A review of 19 studies found CBD induced cancer cell death, inhibited metastasis, enhanced immune response, and improved the effectiveness of cisplatin and radiation in lung cancer models.
Quick Facts
What This Study Found
CBD induced apoptosis through PPAR-gamma activation, mitochondrial dysfunction, and oxidative stress. It inhibited epithelial-to-mesenchymal transition (a driver of metastasis) and enhanced CD8+ T cell and NK cell activity. CBD showed synergy with cisplatin and radiotherapy.
Key Numbers
19 studies included. CBD concentrations: 1-10 uM in cell studies, 200-600 mg/day in human cases. 13 in vitro, 4 animal, 2 clinical reports. CBD enhanced CD8+ T cell and NK cell activity in the tumor microenvironment.
How They Did This
Systematic review following PRISMA guidelines, searching PubMed, Scopus, Web of Science, and Google Scholar for studies from 2007-2025. Included 13 in vitro, 4 in vivo, and 2 clinical reports on CBD in lung cancer.
Why This Research Matters
Lung cancer remains the leading cause of cancer death worldwide. CBD's ability to enhance existing therapies while potentially reducing treatment resistance addresses two major challenges in lung cancer treatment.
The Bigger Picture
Cancer immunotherapy has transformed lung cancer treatment but many patients still do not respond. CBD's immune-modulating effects alongside conventional therapy sensitization suggest potential as an adjunct worth testing.
What This Study Doesn't Tell Us
Primarily preclinical data. Only 2 clinical reports, not controlled trials. CBD doses used in cell studies may not translate to achievable human concentrations. Risk of publication bias in preclinical cancer research.
Questions This Raises
- ?Would CBD improve outcomes in lung cancer immunotherapy combinations?
- ?What dose and route of administration would be needed for clinical benefit?
Trust & Context
- Key Stat:
- CBD enhanced both cisplatin chemotherapy and radiotherapy in preclinical models
- Evidence Grade:
- Systematic review with predominantly preclinical evidence. Two clinical reports provide limited human data, but controlled trials are absent.
- Study Age:
- Published in 2025, literature 2007-2025.
- Original Title:
- The potential role of cannabidiol (CBD) in lung cancer therapy: a systematic review of preclinical and clinical evidence.
- Published In:
- Cancer cell international, 25(1), 369 (2025)
- Authors:
- Esmaeli, Mojtaba(4), Dehghanpour Dehabadi, Maryam(4)
- Database ID:
- RTHC-06414
Evidence Hierarchy
Analyzes all available research on a topic using a structured method.
What do these levels mean? →Frequently Asked Questions
Could CBD help treat lung cancer?
Preclinical studies show CBD can kill lung cancer cells, prevent spread, and enhance chemotherapy and radiation. However, only 2 clinical case reports exist, and no controlled trials have been completed.
Does CBD enhance chemotherapy for lung cancer?
In laboratory studies, CBD increased the effectiveness of cisplatin by improving drug uptake and helping overcome treatment resistance. Clinical trials are needed to confirm this in patients.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-06414APA
Esmaeli, Mojtaba; Dehghanpour Dehabadi, Maryam. (2025). The potential role of cannabidiol (CBD) in lung cancer therapy: a systematic review of preclinical and clinical evidence.. Cancer cell international, 25(1), 369. https://doi.org/10.1186/s12935-025-04010-7
MLA
Esmaeli, Mojtaba, et al. "The potential role of cannabidiol (CBD) in lung cancer therapy: a systematic review of preclinical and clinical evidence.." Cancer cell international, 2025. https://doi.org/10.1186/s12935-025-04010-7
RethinkTHC
RethinkTHC Research Database. "The potential role of cannabidiol (CBD) in lung cancer thera..." RTHC-06414. Retrieved from https://rethinkthc.com/research/esmaeli-2025-the-potential-role-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.